Hippocampal expression and distribution of CB1 receptors in the Amazonian rodent Proechimys: An animal model of resistance to epilepsy

Brain Research

Volumn 1335, Issue , 2010, Pages 35-40

  Araujo, Bruno Henrique Silva ^a   Torres, Laila Brito ^a,b   Cossa, Ana Carolina ^a   Naffah Mazzacoratti, Maria da Graça ^a   Cavalheiro, Esper Abrão ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO EVANDRO CHAGAS   (Brazil)

Author keywords

Cannabinoid receptor 1 (CB1); Epilepsy; Epileptogenesis; Hippocampus; Proechimys

Indexed keywords

CANNABINOID 1 RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE RESISTANCE; EPILEPSY; EPILEPTOGENESIS; EXPERIMENTAL MODEL; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOLECULAR WEIGHT; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROECHIMYS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RODENT; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; CA1 REGION, HIPPOCAMPAL; CA3 REGION, HIPPOCAMPAL; DISEASE MODELS, ANIMAL; EPILEPSY; GENETIC PREDISPOSITION TO DISEASE; HIPPOCAMPUS; IMMUNITY, INNATE; MALE; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RODENTIA; SOUTH AMERICA; SPECIES SPECIFICITY;

ANIMALIA; PROECHIMYS; RATTUS NORVEGICUS; RODENTIA;

EID: 77952237528     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.03.031     Document Type: Article

References (34)

1. Andrioli A., Fabene P.F., Spreafico R., Cavalheiro E.A., and Bentivoglio M. Different patterns of neuronal activation and neurodegeneration in the thalamus and cortex of epilepsy-resistant Proechimys rats versus Wistar rats after pilocarpine-induced protracted seizures. Epilepsia 50 4 (2009) 832-848
2. Arida R.M., Scorza F.A., Carvalho R.A., and Cavalheiro E.A. Proechimys guyannensis: an animal model of resistance to epilepsy. Epilepsia 46 Suppl 5 (2005) 189-197
3. Ben-Ari Y., and Cossart R. Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci. 23 (2000) 580-587
4. Carvalho R.A., Arida R.M., and Cavalheiro E.A. Amygdala kindling in Proechimys guyannensis rat: an animal model of resistence to epilepsy. Epilepsia 44 2 (2003) 165-170
5. Cavalheiro E.A., Fernandes M.J., Turski L., and Naffah-Mazzacoratti M.G. Spontaneous recurrent seizures in rat: amino acid and monoamine determination in the hippocampus. Epilepsia 35 1 (1994) 1-11
6. Egertova M., and Elphick M.R. Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB. J. Comp. Neurol. 422 (2000) 159-171
7. Fabene P.F., Correia L., Carvalho R.A., Cavalheiro E.A., and Bentivoglio M. The spiny rat Proechimys guyannensis as model of resistance to epilepsy: chemical characterization of hippocampal cell populations and pilocarpine induced changes. Neuroscience 104 4 (2001) 979-1002
8. Falenski K.W., Blair R.E., Sim-Selley L.J., Martin B.R., and DeLorenzo R.J. Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy. Neuroscience 25 146 (3) (2007) 1232-1244
9. Freund T.F., Katona I., and Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83 (2003) 1017-1066
10. Gilbert G.L., Kim H.J., Waataja J.J., and Thayer S.A. Delta9-tetrahydrocannabinol protects hippocampal neurons from excitotoxicity. Brain Res. 12 1128 (1) (2007) 61-69
11. Grimes L.M., and Prince D.A. Thalamocortical relay neurons: antidromic invasion of spikes from a cortical epileptogenic focus. Science 176 (1972) 424-426
12. Howlett A.C. The CB1 cannabinoid receptor in the brain. Neurobiol. Dis. 5 (1998) 405-416
13. Karanian D.A., Karim S.L., Wood J.T., Williams J.S., Lin S., Makriyannis A., and Bahr B.A. Endocannabinoid enhancement protects against kainic acid induced seizures and associated brain damage. J. Pharmacol. Exp. Ther. 322 3 (2007) 1059-1066
14. Kim H.J., Waataja J.J., and Thayer S.A. Cannabinoids inhibit network-driven synapse loss between hippocampal neurons in culture. J. Pharmacol. Exp. Ther. 325 3 (2008) 850-858
15. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 1 (1951) 265-275
16. Ludányi A., Eross L., Czirják S., Vajda J., Halász P., Watanabe M., Palkovits T.S.M., Maglóczky Z., Freund T.F., and Katona I. Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. J. Neurosci. 19 28(12) (2008) 2976-2990
17. Lutz B. On demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochem. Pharmacol. Toxicol. 46 (2004) 101-122
18. Mailleux P., and Vanderhaeghen J.J. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48 (1992) 655-668
19. Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S.C., Cascio M.G., Gutiérrez S.O., Van der Stelt M., López-Rodriguez M.L., Casanova E., Schütz G., Zieglgänsberger W., Di Marzo V., Behl C., and Lutz B. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302 5642 (2003) 84-88
20. Moldrich G., and Wenger T. Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study. Peptides 21 11 (2000) 1735-1742
21. Monory K., Massa F., Egertová M., Eder M., Blaudzun H., Westenbroek R., Kelsch W., Jacob W., Marsch R., Ekker M., Long J., Rubenstein J.L., Goebbels S., Nave K.A., During M., Klugmann M., Wölfel B., Dodt H.U., Zieglgänsberger W., Wotjak C.T., Mackie K., Elphick M.R., Marsicano G., and Lutz B. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51 4 (2006) 455-466
22. Paxinos G., and Watson C. The rat brain in stereotaxic coordinate. Compact Third Edition (1996), Academic Press, New York
23. Pazos M.R., Núñez E., Benito C., Tolón R.M., and Romero J. Functional neuroanatomy of the endocannabinoid system. Pharmacol. Biochem. Behav. 81 2 (2005) 239-247
24. Pettit D.A., Harrison M.P., Olson J.M., Spencer R.F., and Cabral G.A. Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J. Neurosci. Res. 51 3 (1998) 391-402
25. Pitkänen A., and Sutula T.P. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol. 1 3 (2002) 173-181
26. Qi J.S., Yao J., Fang C., Luscher B., and Chen G. Downregulation of tonic GABA currents following epileptogenic stimulation of rat hippocampal cultures. J. Physiol. 577 2 (2006) 579-590
27. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32 3 (1972) 281-294
28. Rocha L., Arida R.M., Carvalho R.A., Scorza F.A., Neri-Bazan L., and Cavalheiro E.A. GABA and opioid binding distribution in the brain of the seizureresistant Proechimys guyannensis: an autoradiography study. Synapse 60 5 (2006) 392-398
29. Sloviter R.S. Feedforward an feedback inhibition of hippocampal principal cell activity evoked by perforant path stimulation: GABA-mediated mechanisms that regulate excitability in vivo. Hippocampus 1 (1991) 31
30. Somogy P., Nunzi M.G., Gorio A., and Smith A.D. A new type of specific interneuron in the monkey hippocampus forming synapses exclusively with the axon initial segments of pyramidal cells. Brain Res. 259 (1983) 137-142
31. Van Vliet E.A., Aronica E., Tolner E.A., Lopes da Silva F.H., and Gorter J.A. Progression of temporal lobe epilepsy in the rat is associated with immunocytochemical changes in inhibitory interneurons in specific regions of the hippocampal formation. Exp. Neurol. 187 2 (2004) 367-379
32. Wallace M.J., Wiley J.L., Martin B.R., and DeLorenzo R.J. Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects. Eur. J. Pharmacol. 428 (2001) 51-57
33. Wallace M.J., Martin B.R., and DeLorenzo R.J. Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur. J. Pharmacol. 452 3 (2002) 295-301
34. Wallace M.J., Blair R.E., Falenski K.W., Martin B.R., and DeLorenzo R.J. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J. Pharmacol. Exp. Ther. 307 (2003) 129-137